CSIMarket
 
Merit Medical Systems Inc  (NASDAQ: MMSI)
Other Ticker:  
 
 
Price: $109.3100 $1.30 1.204%
Day's High: $109.36 Week Perf: -0.89 %
Day's Low: $ 107.78 30 Day Perf: 14 %
Volume (M): 447 52 Wk High: $ 111.45
Volume (M$): $ 48,851 52 Wk Avg: $89.09
Open: $108.57 52 Wk Low: $70.70



 Market Capitalization (Millions $) 6,508
 Shares Outstanding (Millions) 60
 Employees 6,950
 Revenues (TTM) (Millions $) 1,323
 Net Income (TTM) (Millions $) 120
 Cash Flow (TTM) (Millions $) 465
 Capital Exp. (TTM) (Millions $) 42

Merit Medical Systems Inc
Merit Medical Systems Inc is a leading manufacturer and marketer of disposable medical devices used in interventional, diagnostic and therapeutic procedures. The company was founded in 1987 by Fred P. Lampropoulos, who is the current CEO and Chairman of the Board of Directors.

Merit Medical Systems operates in three main business segments: Cardiovascular, Endoscopy and Peripheral Intervention. Its products range from vascular access products, such as catheters and guidewires, to embolization devices and drainage catheters. The company also provides customized kits and trays for specific procedures.

The headquarters of Merit Medical Systems is located in Salt Lake City, Utah, USA, but it has more than 5,000 employees worldwide and operations in more than 60 countries. The company has a strong global presence, with distribution centers in Europe, Asia, Latin America and the Middle East.

Merit Medical Systems is known for its commitment to innovation and its focus on customer satisfaction. It invests heavily in research and development to develop new products and improve existing ones. The company has also acquired several other medical device companies over the years to expand its product portfolio and global reach.

Merit Medical Systems has received numerous awards and recognitions for its products and services. It has been named among the best places to work in Utah and has been recognized for its commitment to sustainability and social responsibility.

In conclusion, Merit Medical Systems Inc is a leading medical device company with a global presence in the interventional, diagnostic and therapeutic procedures market. The company has a long history of innovation, customer satisfaction, and commitment to sustainability and social responsibility.


   Company Address: 1600 West Merit Parkway South Jordan 84095 UT
   Company Phone Number: 253-1600   Stock Exchange / Ticker: NASDAQ MMSI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX   -4.36%    
BDX   -7.11%    
BSX        2.84% 
MDT        0.31% 
SYK        1.83% 
ZBH   -4.72%    
• View Complete Report
   



Clinical Study

FDA Grants Premarket Approval for Merit Medicals WRAPSODY Cell-Impermeable Endoprosthesis

Published Fri, Dec 20 2024 2:15 PM UTC

Abstract: The U.S. Food and Drug Administration (FDA) has granted premarket approval to the WRAPSODY Cell-Impermeable Endoprosthesis, a novel medical device developed by Merit Medical Systems, Inc. This regulatory milestone is expected to allow the commercialization of the device within the United States beginning in 2025, marking a significant advancement in healthcare tech...

Management Changes

Navigating Change: Merit Medicals Leadership Shift Amidst Promising Innovations

Published Mon, Dec 16 2024 9:00 PM UTC

In a pivotal moment for Merit Medical Systems, Inc., the company has announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. This transition comes at a critical juncture as the company contemplates its strategic direction amidst mixed financial performance and a significant regulatory achievement.Despite Wright s departure, Merit Medical has ...

Clinical Study

Beyond the Graft Establishing New Frontiers in Arteriovenous Graft Maintenance with Merit Medical?s WRAPSODY Stent ...

Published Mon, Nov 25 2024 2:15 PM UTC

Abstract Arteriovenous grafts (AVGs) are crucial for hemodialysis in patients with end-stage renal disease. These patients are, however, challenged by high failure rates due to stenosis and thrombosis. Current methodologies to maintain patency of these grafts have limited effectiveness, necessitating frequent interventions. This article examines the findings from the WRAPSOD...

Merger and Acquisition

Merit Medical Systems Acquires Cook Medicals Lead Management Portfolio for $210 Million, Shares Surge as Company Eyes Growth

Published Fri, Nov 1 2024 1:15 PM UTC

Breaking News: Merit Medical Systems Completes Strategic Acquisition of Cook Medical Lead Management PortfolioSOUTH JORDAN, Utah, Nov. 01, 2024 ? Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading player in the healthcare technology sector, announced today the completion of its acquisition of Cook Medical s lead management portfolio. This significant transaction, valued a...

Stock Market Announcement

Merit Medical Systems to Acquire Cook Medical?s Lead Management Portfolio for $210 Million,

Published Tue, Sep 17 2024 11:00 AM UTC



Merit Medical Systems to Acquire Lead Management Portfolio from Cook Medical for $210 Million
SOUTH JORDAN, Utah, Sept. 17, 2024 Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, has announced a definitive asset purchase agreement to acquire Cook Medical?s lead management portfolio for approximately $210 million in cash. T...







Merit Medical Systems Inc's Segments
United States    60.82 % of total Revenue
International    39.28 % of total Revenue
Cardiovascular    95.09 % of total Revenue
Cardiovascular Peripheral Intervention    40.62 % of total Revenue
Cardiovascular Cardiac Intervention    26.73 % of total Revenue
Cardiovascular Custom Procedural Solutions    14.95 % of total Revenue
Cardiovascular OEM    12.78 % of total Revenue
Cardiovascular United States    56.06 % of total Revenue
Cardiovascular United States Peripheral Intervention    24.8 % of total Revenue
Cardiovascular United States Cardiac Intervention    10.97 % of total Revenue
Cardiovascular United States Custom Procedural Solutions    9.06 % of total Revenue
Cardiovascular United States OEM    11.22 % of total Revenue
Cardiovascular International    39.03 % of total Revenue
Cardiovascular International Peripheral Intervention    15.82 % of total Revenue
Cardiovascular International Cardiac Intervention    15.76 % of total Revenue
Cardiovascular International Custom Procedural Solutions    5.89 % of total Revenue
Cardiovascular International OEM    1.56 % of total Revenue
Endoscopy    5 % of total Revenue
Endoscopy Endoscopy Devices    5 % of total Revenue
Endoscopy United States Endoscopy Devices    4.76 % of total Revenue
Endoscopy International Endoscopy Devices    0.24 % of total Revenue

  Merit Medical Systems Inc Outlook

On February 28 2024 the Merit Medical Systems Inc provided following guidance

Merit Medical Systems Inc. reported its financial results for the fourth quarter and year ended December 31, 2023, and provided guidance for fiscal year 2024. The company's constant currency revenue, organic revenue, non-GAAP EPS, non-GAAP net income, non-GAAP operating income and margin, non-GAAP gross profit and margin, and free cash flow were all highlighted as important non-GAAP financial measures.

The company emphasized that these non-GAAP financial measures are important in evaluating its performance and provided a reconciliation of these measures to their most directly comparable GAAP financial measures.

Looking ahead to fiscal year 2024, Merit Medical Systems Inc. expects to see continu...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com